Diagnostic methods and systems for quantifying APO AI
US5055396A · kind A · utility
23Cited by
1References
15Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 2, 1987 |
| Grant date | Oct 8, 1991 |
| Priority date | — |
| Expiry date | Nov 2, 2007 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY10S530/806
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The present invention describes a monoclonal antibody that is directed against an Apo AI/HLD epitope whose expression is substantially unaffected by deamidation. Also disclosed is a polypeptide capable of immunologically mimicking an Apo AI/HLD epitope whose expression is substantially unaffected by deamidation. Diagnostic systems and methods for determining the amount of Apo AI in a vascular fluid sample using a disclosed monoclonal antibody and/or a disclosed polypeptide are also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.